Research Material • Semax
Semax Peptide Research Material
Semax is a synthetic heptapeptide research material structurally
related to a fragment of adrenocorticotropic hormone (ACTH).
It is investigated in controlled experimental systems involving
peptide signaling, molecular interactions, gene-expression
pathways, and neurobiological research models.
Semax
Heptapeptide
ACTH-Fragment Derived
Lyophilized Material
Batch Traceability
Research Use Only
Not for human or veterinary use, administration, ingestion,
injection, compounding, diagnostic, therapeutic, clinical,
or personal use.
01
Compound Profile
Semax Research Material
Semax is a synthetic peptide composed of seven amino-acid
residues. Its sequence incorporates an ACTH-derived peptide
fragment together with a C-terminal Pro-Gly-Pro sequence,
providing a defined molecular structure for experimental
peptide research.
Scientific literature has examined Semax in laboratory and
preclinical models involving molecular signaling, peptide
interactions, transcriptional responses, and neurobiological
pathways.
Royal Peptides supplies Semax strictly as a laboratory research
material. References to published areas of investigation describe
scientific context only and do not represent intended therapeutic
or clinical uses of this product.
02
Molecular Identification
Defined Heptapeptide Sequence
Semax has a defined seven-residue peptide sequence. Its established
molecular identity allows researchers to incorporate a specific,
traceable peptide material into controlled analytical and
experimental workflows.
Compound
Semax
Research peptide
Classification
Heptapeptide
Seven amino-acid residues
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Defined synthetic sequence
Material Format
Lyophilized
Laboratory research material
03
Structural Context
ACTH-Fragment Derived Research Peptide
Semax is structurally associated with the ACTH(4–7) peptide
fragment and incorporates a Pro-Gly-Pro sequence at its
C-terminal region. This defined architecture provides a basis
for comparative peptide and structure-function investigations.
Defined Seven-Residue Structure
The established sequence provides a specific molecular
identity for analytical characterization and controlled
laboratory investigation.
ACTH-Fragment Relationship
Semax contains a sequence structurally associated with the
ACTH(4–7) fragment, providing a defined context for
comparative peptide research.
Pro-Gly-Pro Sequence
A Pro-Gly-Pro sequence forms the C-terminal portion of
Semax and contributes to its defined seven-residue
molecular identity.
Structure-Function Research
Controlled models may compare peptide sequence,
molecular structure, analytical characteristics, and
experimentally measurable variables.
04
Scientific Context
Controlled Semax Research
Published experimental literature involving Semax spans several
molecular and neurobiological research areas. These areas describe
experimental investigation rather than intended uses of the
research material supplied on this page.
Peptide Signaling Research
Experimental systems may examine Semax in relation to
peptide-associated signaling pathways and measurable
molecular responses.
Gene-Expression Research
Experimental models have investigated changes in molecular
and transcriptional variables associated with Semax under
defined research conditions.
Neurobiological Models
Semax appears in laboratory and preclinical literature
involving neurobiological pathways and experimentally
measurable molecular variables.
Molecular Interaction Studies
Controlled experimental systems may be used to investigate
interactions between Semax and selected molecular pathways
or biological research targets.
05
Analytical Documentation
Batch-Specific Research Information
Laboratory evaluation should rely on analytical documentation
associated with the specific Semax production lot under
investigation. General product-page information should not
replace applicable batch-specific analytical records.
- Compound identification
- Production lot or batch reference
- Declared material quantity
- Analytical testing information
- Purity information where applicable
- Testing methodology where documented
- Certificate of Analysis information where available
- Research material traceability
06
Traceability
Research Records & Lot Control
Appropriate laboratory records help maintain traceability
between experimental observations and the specific Semax
production lot incorporated into a research workflow.
Material Identification
Record the Semax identity, stated material quantity,
applicable production lot or batch reference, date received,
and relevant internal laboratory identifier.
Analytical Records
Preserve applicable analytical documentation, experimental
observations, results, storage records, and other research
records associated with the material.
07
Laboratory Protocol
Handling & Storage
Semax research material should be handled using appropriate
laboratory procedures designed to preserve material identity,
minimize contamination, and maintain experimental traceability.
Professional Laboratory Handling
Handle using appropriate laboratory practices and equipment.
Maintain clear material identification throughout receipt,
storage, analytical preparation, and experimental workflows.
Storage & Records
Follow storage information associated with the applicable
product label and batch documentation. Maintain appropriate
laboratory storage and material-control records.
08
Important Restrictions
Research Use Limitations
Royal Peptides Semax is supplied exclusively as a laboratory
research material. It is not offered or represented as a medicine,
pharmaceutical preparation, dietary supplement, food, cosmetic,
or consumer health product.
- Not for human administration
- Not for veterinary administration
- Not for ingestion or injection
- Not for personal experimentation
- Not for pharmaceutical compounding
- Not for pharmacy preparation
- Not for diagnostic or therapeutic use
- Not for clinical use
09
Research FAQ
Semax Research Questions
What is Semax?
Semax is a synthetic seven-amino-acid peptide structurally
related to an ACTH-derived peptide fragment. Royal Peptides
supplies it strictly as a laboratory research material.
How many amino acids are in Semax?
Semax contains seven amino-acid residues and is therefore
classified as a heptapeptide.
What is the Semax peptide sequence?
Semax is commonly identified by the sequence
Met-Glu-His-Phe-Pro-Gly-Pro. Researchers should rely on
documentation corresponding to the specific production
lot being evaluated.
How is Semax related to ACTH?
Semax incorporates a peptide sequence structurally associated
with the ACTH(4–7) fragment together with a Pro-Gly-Pro
sequence. This relationship provides molecular context for
laboratory peptide research.
What research areas involve Semax?
Published experimental research involving Semax includes
peptide signaling, molecular interactions, gene-expression
pathways, and neurobiological research models. These are
scientific research contexts, not intended uses of this
product.
How is Semax different from Selank?
Semax and Selank are separate synthetic heptapeptides with
different amino-acid sequences and structural origins.
Researchers should treat them as distinct materials and
maintain separate compound and batch records.
Is Semax intended for human use?
No. Royal Peptides supplies Semax strictly for laboratory
research. It is not intended for human or veterinary
administration.
Does Royal Peptides provide dosing or administration instructions?
No. Royal Peptides does not provide dosing, administration,
injection, prescribing, treatment, or personal-use
instructions for Semax.
Why is the production lot important?
Batch-specific analytical documentation corresponds to a
particular production lot. Recording the applicable lot
reference supports traceability between the research material,
analytical documentation, and laboratory records.
Is analytical documentation available?
Batch-specific analytical documentation may be available
for the applicable production lot. Researchers should review
documentation corresponding to the specific material received.
Research Use Only
Laboratory Research Material
Semax is supplied for laboratory research use only. Not for human
or veterinary use. Not intended for administration, ingestion,
injection, personal experimentation, pharmaceutical compounding,
pharmacy preparation, diagnostic use, therapeutic use, or clinical
use. Nothing on this page constitutes medical advice or represents
this research material as intended to diagnose, treat, cure,
mitigate, or prevent any disease or medical condition.